DUBLIN (AP) _ Horizon Pharma Inc. (HZNP) on Monday reported a second-quarter loss of $209.5 million, after reporting a profit in the same period a year earlier.
The Dublin-based company said it had a loss of $1.29 per share. Earnings, adjusted for non-recurring costs, were 41 cents per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 12 cents per share.
The drugmaker posted revenue of $289.5 million in the period.
Horizon Pharma expects full-year revenue in the range of $1.01 billion to $1.05 billion.
Horizon Pharma shares have dropped 22 percent since the beginning of the year. The stock has dropped 37 percent in the last 12 months.
(Sources: AP, Automated Insights)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
Filed Under: Drug Discovery
